| Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent J Yuan, S Guo, D Hall, AM Cammett, S Jayadev, M Distel, S Storfer, ... Aids 25 (10), 1271-1280, 2011 | 172 | 2011 |
| Molecular Evolution of Drosophila Odorant Receptor Genes S Guo, J Kim Molecular biology and evolution 24 (5), 1198-1207, 2007 | 158 | 2007 |
| Molecular pathology of patient tumors, patient-derived xenografts, and cancer cell lines S Guo, W Qian, J Cai, L Zhang, JP Wery, QX Li Cancer research 76 (16), 4619-4626, 2016 | 61 | 2016 |
| The design, analysis and application of mouse clinical trials in oncology drug development S Guo, X Jiang, B Mao, QX Li BMC cancer 19, 1-14, 2019 | 59 | 2019 |
| Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model J Jiang, DD Wang, M Yang, D Chen, L Pang, S Guo, J Cai, JP Wery, L Li, ... Oncotarget 6 (17), 15639, 2015 | 46 | 2015 |
| Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment Y Jin, X An, B Mao, R Sun, R Kumari, X Chen, Y Shan, M Zang, L Xu, ... Scientific Reports 12 (1), 3278, 2022 | 40 | 2022 |
| Dissecting the molecular mechanism of Drosophila odorant receptors through activity modeling and comparative analysis S Guo, J Kim Proteins: Structure, Function, and Bioinformatics 78 (2), 381-399, 2010 | 32 | 2010 |
| A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations D Chen, X Huang, J Cai, S Guo, W Qian, JP Wery, QX Li Oncotarget 6 (38), 40815, 2015 | 22 | 2015 |
| Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models B Hong, Y Yang, S Guo, S Duoerkun, X Deng, D Chen, S Yu, W Qian, Q Li, ... Oncotarget 8 (30), 49839, 2017 | 20 | 2017 |
| Large-scale simulation of RNA macroevolution by an energy-dependent fitness model S Guo, LS Wang, J Kim arXiv preprint arXiv:0912.2326, 2009 | 19 | 2009 |
| Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification T Liu, J Rao, W Hu, B Cui, J Cai, Y Liu, H Sun, X Chen, Y Tang, J Chen, ... Nature Communications 13 (1), 1640, 2022 | 18 | 2022 |
| A subset of esophageal squamous cell carcinoma patient-derived xenografts respond to cetuximab, which is predicted by high EGFR expression and amplification H Zhu, C Wang, J Wang, D Chen, J Deng, J Deng, J Fan, H Badakhshi, ... Journal of Thoracic Disease 10 (9), 5328, 2018 | 18 | 2018 |
| Nevirapine Toxicogenomics study team. Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent J Yuan, S Guo, D Hall, AM Cammett, S Jayadev, M Distel, S Storfer, ... Aids 25 (10), 1271-1280, 2011 | 17 | 2011 |
| Authentication, characterization and contamination detection of cell lines, xenografts and organoids by barcode deep NGS sequencing X Chen, W Qian, Z Song, QX Li, S Guo NAR Genomics and Bioinformatics 2 (3), lqaa060, 2020 | 15 | 2020 |
| Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes SH Lee, SY Yim, YS Jeong, QX Li, SH Kang, BH Sohn, SV Kumar, ... Hepatology 76 (6), 1634-1648, 2022 | 14 | 2022 |
| Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature S Guo, D Chen, X Huang, J Cai, JP Wery, QX Li Oncotarget 7 (31), 50575, 2016 | 14 | 2016 |
| Identification of novel proteins interacting with vascular endothelial growth inhibitor 174 in renal cell carcinoma Q Zhao, D Kun, B Hong, X Deng, S Guo, X Tang, Y Yang, K Gong, Q Li, ... Anticancer Research 37 (8), 4379-4388, 2017 | 13 | 2017 |
| HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models H Ke, F Zhang, J Wang, L Xiong, X An, X Tu, C Chen, Y Wang, B Mao, ... Scientific Reports 13 (1), 5419, 2023 | 12 | 2023 |
| Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population Q Zhao, J Xue, B Hong, W Qian, T Liu, B Fan, J Cai, Y Ji, J Liu, Y Yang, ... Cancer Cell International 20, 1-14, 2020 | 10 | 2020 |
| Creating matched in vivo/in vitro patient-derived model pairs of PDX and PDX-derived organoids for cancer pharmacology research X Xu, L Shang, P Wang, J Zhou, X Ouyang, M Zheng, B Mao, L Zhang, ... JoVE (Journal of Visualized Experiments), e61382, 2021 | 9 | 2021 |
